Tsunemitsu, Takefumi
22  results:
Search for persons X
?
10

Normal Q-Q plot:

Takefumi Tsunemitsu (10162264) ; Yuki Kataoka (3219834) ; Masaru Matsumoto (2999163)..
https://figshare.com/articles/journal_contribution/Normal_Q-Q_plot_/17301249.  , 2021
 
?
11

Study outcomes:

Takefumi Tsunemitsu (10162264) ; Yuki Kataoka (3219834) ; Masaru Matsumoto (2999163)..
https://figshare.com/articles/dataset/Study_outcomes_/17301291.  , 2021
 
?
12

Flow chart of study population:

Takefumi Tsunemitsu (10162264) ; Yuki Kataoka (3219834) ; Masaru Matsumoto (2999163)..
https://figshare.com/articles/figure/Flow_chart_of_study_population_/17301273.  , 2021
 
?
13

Additional file 1 of Prevalence of post-intensive care synd..:

Daisuke Kawakami (10162243) ; Shigeki Fujitani (3843739) ; Takeshi Morimoto (540391)...
https://figshare.com/articles/journal_contribution/Additional_file_1_of_Prevalence_of_post-intensive_care_syndrome_among_Japanese_intensive_care_unit_patients_a_prospective_multicenter_observational_J-PICS_study/14053801.  , 2021
 
?
14

Neuroactive drugs and analgesics during MV through an oral ..:

Takefumi Tsunemitsu (10162264) ; Yuki Kataoka (3219834) ; Masaru Matsumoto (2999163)..
https://figshare.com/articles/dataset/Neuroactive_drugs_and_analgesics_during_MV_through_an_oral_ET_tube_/17301285.  , 2021
 
?
15

Comparison between all patients receiving and not receiving..:

Takefumi Tsunemitsu (10162264) ; Yuki Kataoka (3219834) ; Masaru Matsumoto (2999163)..
https://figshare.com/articles/journal_contribution/Comparison_between_all_patients_receiving_and_not_receiving_SPM_/17301243.  , 2021
 
1-15